Literature DB >> 28359750

Can lifestyle changes prevent cognitive impairment?

Miia Kivipelto1, Francesca Mangialasche2, Tiia Ngandu3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28359750     DOI： 10.1016/S1474-4422(17)30080-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  7 in total

1.  Free and cued selective reminding test predicts progression to Alzheimer's disease in people with mild cognitive impairment.

Authors:  Giulia Grande; Nicola Vanacore; Davide L Vetrano; Ilaria Cova; Debora Rizzuto; Flavia Mayer; Laura Maggiore; Roberta Ghiretti; Valentina Cucumo; Claudio Mariani; Stefano F Cappa; Simone Pomati
Journal:  Neurol Sci       Date:  2018-07-26       Impact factor: 3.307

2.  Lessons from the Multidomain Alzheimer Preventive Trial.

Authors:  Hussein N Yassine; Lon S Schneider
Journal:  Lancet Neurol       Date:  2017-07-11       Impact factor: 44.182

3.  The contrasting role of technology as both supportive and hindering in the everyday lives of people with mild cognitive deficits: a focus group study.

Authors:  Eva Lindqvist; Annika PerssonVasiliou; Amy S Hwang; Alex Mihailidis; Arlene Astelle; Andrew Sixsmith; Louise Nygård
Journal:  BMC Geriatr       Date:  2018-08-17       Impact factor: 3.921

Review 4.  Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer's Disease and Related Dementias: A Review of Completed and Prospective Studies.

Authors:  Nicholas T Bott; Aidan Hall; Erica N Madero; Jordan M Glenn; Nami Fuseya; Joshua L Gills; Michelle Gray
Journal:  Nutrients       Date:  2019-09-19       Impact factor: 5.717

5.  Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and Progress.

Authors:  S Sindi; C Thunborg; A Rosenberg; P Andersen; S Andrieu; L M Broersen; N Coley; C Couderc; C Z Duval; G Faxen-Irving; G Hagman; M Hallikainen; K Håkansson; J Lehtisalo; N Levak; F Mangialasche; J Pantel; E Kekkonen; A Rydström; A Stigsdotter-Neely; A Wimo; T Ngandu; H Soininen; T Hartmann; A Solomon; M Kivipelto
Journal:  J Prev Alzheimers Dis       Date:  2022

6.  Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease.

Authors:  Alexa Pichet Binette; Étienne Vachon-Presseau; John Morris; Randall Bateman; Tammie Benzinger; D Louis Collins; Judes Poirier; John C S Breitner; Sylvia Villeneuve
Journal:  Biol Psychiatry       Date:  2020-02-06       Impact factor: 13.382

7.  Fibronectin type III domain-containing protein 5 interacts with APP and decreases amyloid β production in Alzheimer's disease.

Authors:  Yasuha Noda; Akira Kuzuya; Kyousuke Tanigawa; Mitsugu Araki; Ryoko Kawai; Biao Ma; Yoko Sasakura; Masato Maesako; Yoshitaka Tashiro; Masakazu Miyamoto; Kengo Uemura; Yasushi Okuno; Ayae Kinoshita
Journal:  Mol Brain       Date:  2018-10-24       Impact factor: 4.041
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.